Please Wait...

Protocol Design and Expert Reporting

Study design and Consultative Services

In this highly dynamic and competitive business environment, it is important to have a partner that can help you successfully navigate through the complex drug development process. Whether your team is ready to conduct your company's first TQT study, needs assistance in determining study design options and technology for defining a blood pressure signal for your protocol, or advanced training on medical imaging best practices, Bioclinica can help. We provide a full range of consultancy and reporting services supporting cardiovascular safety throughout the clinical development of your compound.

Our services include:

  • Expert protocol development and study design
  • Statistical analysis plans
  • Expert summary reports for inclusion in the Clinical Study Report
  • Regulatory guidance and support
  • Charter development

Bioclinica is committed to providing you with the highest level of service. The team assigned to your cardiac safety study will provide expert advice on clinical and regulatory strategy, tailored to the framework of your program and specific compound. Engage our team of experts early to assist in developing an effective, comprehensive drug development program and trial protocol.

Cardiac Safety Analysis and Expert Reporting

Bioclinica recognizes the need to provide comprehensive services from study design and conduct to expert reporting of cardiac safety data. We possess strong capabilities in analyzing and presenting ECG/ABPM/CV data in regulatory, expert report format, and we support regulatory meetings and presentations. Our statistical and medical writing team has authored more than 250 expert reports, most of which supported regulatory submissions and full TQT protocol development.


Cardiovascular Solutions


Global Median Beat (GMB)


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Join @bioclinica's Research Dev. Dir. Marieke Cajal, PhD @adpdnet 3/18 where she will speak on patient engagement…
bioclinica (22 hours ago)
Still on the fence about #eSource? Here R some key considerations & inside tips for successful implementation & how…
bioclinica (Yesterday)
Almost here! #ASCPT2018 Tour central Florida's premier Phase 1 facility at our Open House 3/22! Meet our team & see…
bioclinica (Yesterday)
RT @FDAWomen: Today we welcomed minority health stakeholders during FDA’s first Minority Health Listening Session. Thank you for this discu…
bioclinica (Yesterday)
RT @melfass: The House has rejected the "Right to Try" bill, opponents of which said would have compromised the #clinicaltrials process. cc…
bioclinica (Yesterday)
RT @eClinical_Jen: Here what the FDA has to say on using Microsoft Excel for Clinical Trial data: #eHealth #Pharm…
bioclinica (Yesterday)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen